Fund Advisors of America »

Crispr Therapeutics shares owned by Fund Advisors of America

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Fund Advisors of America from 13F filings

Historical chart of Fund Advisors of America investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Fund Advisors of America consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Fund Advisors of America

Quarter filed Position value Share count Share price at filing
2025-12-31 $398k 7.6k 52.44

More positions owned by Fund Advisors of America

NVIDIA Corporation (NVDA)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Main Street Capital Corporation (MAIN)
International Business Machines (IBM)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Etfis Ser Tr I Virtus Infrcap (PFFA)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Marvell Technology (MRVL)
Fs Credit Opportunities Corp Common Stock (FSCO)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr Gold Tr Gold Shs (GLD)
Cloudflare Cl A Com (NET)

View all positions for Fund Advisors of America

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital Research and Management Company - Division 3
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics